Sam Jaffe | Jul 7, 2002 | 5 min read
You've just started your job with a small biotech startup that has some promising drug candidates and a freewheeling culture. You enjoy the shorts and T-shirt dress code and the midnight pizza parties for late workers, as well as the generous stock options. But then it's announced that your company has sold a large equity stake to a mega-pharmaceutical company. Now you're expected to wear a suit when meeting with your partners. To make matters worse, the large equity stake the pharma company